crowdreviews.com

Strategic Partner

May 8, 2017 - May 10, 2017

8th International Conference and Exhibition on Metabolomics & Systems Biology

Holiday Inn Singapore Atrium, 317 Outram Road, Singapore

Map Event Location Contact Organizer Share this Event

Event Details

Begins: May 8, 2017

End: May 10, 2017

Event Location: Holiday Inn Singapore Atrium, 317 Outram Road, Singapore

Website: http://www.metabol..rence.com

Event Organizer

Event Organizer: Conference Series

Contact Person: Isaac Samuel

Phone Number: 1-702-508-5200 Ext:8037

Website: https://www.conferenceseries.com/

Overview

Conference Series LLC welcomes you to attend the 8th International Conference and Exhibition on Metabolomics & Systems Biology during May 08-10, 2017 Singapore. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. The main theme of the conference is “Rise of New Era in Metabolomics Research”.

Metabolomics Congress 2017  Conference will be an exploration of  New  research Innovation of Metabolomics and cover the latest developments and trends in Metabolomics modeling, Proteomics, Systems Biology, Genomics, Precision Medicine, Lipidomics, LC-MS and GC-MS Techniques, Bioinformatics, Plant Metabolomics, Clinical metabolomics, cancer and metabolism, computational biology, metabolomics syndrome, Nutritional Metabolomics, Therapeutic Metabolomics and more. Metabolomics is of interest to physicians because it may lead to improvements in the diagnosis and treatments of human diseases. Conference Series LLC Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide. The global metabolomics market is expected to grow at a strong CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,100 million by 2019. The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing.


BECOME A STRATEGIC PARTNER

We are looking to build strategic relationships with conference and event organizers paving the way for industry advancements and education.